John Ransom
Stock Analyst at Raymond James
(4.65)
# 97
Out of 4,818 analysts
226
Total ratings
63.45%
Success rate
15.23%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $436.21 | +23.79% | 13 | Apr 21, 2025 | |
RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $50.91 | +27.68% | 11 | Mar 5, 2025 | |
CI The Cigna Group | Reiterates: Strong Buy | $415 → $360 | $334.44 | +7.64% | 17 | Jan 31, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $336.10 | - | 21 | Nov 22, 2024 | |
THC Tenet Healthcare | Downgrades: Outperform | $195 | $121.10 | +61.02% | 17 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $2.49 | - | 8 | Nov 22, 2024 | |
SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $80.90 | +5.07% | 12 | Nov 1, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.67 | +114.36% | 2 | May 16, 2024 | |
EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $101.18 | -6.10% | 15 | Apr 26, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.03 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $93.11 | - | 14 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $264.91 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.23 | +63.53% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $24.93 | +20.34% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $18.35 | -34.60% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $65.85 | +29.08% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $100.07 | +4.93% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $1.81 | +452.49% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.58 | - | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.94 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.95 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $21.72 | +360.41% | 8 | Aug 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $36.71 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $32.16 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $140.15 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.24 | - | 2 | Aug 9, 2017 |
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $436.21
Upside: +23.79%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $50.91
Upside: +27.68%
The Cigna Group
Jan 31, 2025
Reiterates: Strong Buy
Price Target: $415 → $360
Current: $334.44
Upside: +7.64%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $336.10
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $121.10
Upside: +61.02%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.49
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $80.90
Upside: +5.07%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.67
Upside: +114.36%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $101.18
Upside: -6.10%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.03
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $93.11
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $264.91
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $12.23
Upside: +63.53%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $24.93
Upside: +20.34%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $18.35
Upside: -34.60%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $65.85
Upside: +29.08%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $100.07
Upside: +4.93%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $1.81
Upside: +452.49%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.58
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.94
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.95
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $21.72
Upside: +360.41%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $36.71
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $32.16
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $140.15
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.24
Upside: -